Rudiger, A., Breitenstein, A., Arrigo, M., Salzberg, S. P., & Bettex, D. (2014). Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients. Hindawi Publishing Corporation.
Styl ChicagoRudiger, Alain, Alexander Breitenstein, Mattia Arrigo, Sacha P. Salzberg, a Dominique Bettex. Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients. Hindawi Publishing Corporation, 2014.
Citace podle MLARudiger, Alain, et al. Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients. Hindawi Publishing Corporation, 2014.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..